Nutritional Status and Nutritional Support Before and After Pancreatectomy for Pancreatic Cancer and Chronic Pancreatitis

被引:40
作者
Vasiliki Th. Karagianni
Apostolos E. Papalois
John K. Triantafillidis
机构
[1] Department of Gastroenterology Center for Inflammatory Bowel Disease, Saint Panteleimon General Hospital, 18454 Nikaia, Athens
[2] Experimental-Research Center, ELPEN Pharmaceuticals, 19009 Pikermi, Athens
[3] Haidari, 12461
关键词
Chronic pancreatitis; Nutritional status; Nutritional support; Pancreatectomy; Pancreatic cancer;
D O I
10.1007/s13193-012-0189-4
中图分类号
学科分类号
摘要
Cachexia, malnutrition, significant weight loss, and reduction in food intake due to anorexia represent the most important pathophysiological consequences of pancreatic cancer. Pathophysiological consequences result also from pancreatectomy, the type and severity of which differ significantly and depend on the type of the operation performed. Nutritional intervention, either parenteral or enteral, needs to be seen as a method of support in pancreatic cancer patients aiming at the maintenance of the nutritional and functional status and the prevention or attenuation of cachexia. Oral nutrition could reduce complications while restoring quality of life. Enteral nutrition in the post-operative period could also reduce infective complications. The evidence for immune-enhanced feed in patients undergoing pancreaticoduodenectomy for pancreatic cancer is supported by the available clinical data. Nutritional support during the post-operative period on a cyclical basis is preferred because it is associated with low incidence of gastric stasis. Postoperative total parenteral nutrition is indicated only to those patients who are unable to be fed orally or enterally. Thus nutritional deficiency is a relatively widesoread and constant finding suggesting that we must optimise the nutritional status both before and after surgery. © 2012 Indian Association of Surgical Oncology.
引用
收藏
页码:348 / 359
页数:11
相关论文
共 70 条
  • [21] Chang E.B., Bergenstal R.M., Field M., Diarrhea in streptozocin-treated rats. Loss of adrenergic regulation of intestinal fluid and electrolyte transport, J Clin Invest, 75, pp. 1666-1670, (1985)
  • [22] Pappas S., Krzywda E., McDowell N., Nutrition and pancreaticoduodenectomy, Nutr Clin Pract, 25, pp. 234-243, (2010)
  • [23] Seeman E., Melton III U., O'Fallon W.M., Riggs B.L., Risk factors for spinal osteoporosis in men, Am J Med, 75, pp. 977-983, (1983)
  • [24] Bajorunas D.R., Fortner J.G., Jaspan J., Sherwin R.S., Total pancreatectomy increases the metabolic response to glucagon in humans, J Clin Endocrinol Metab, 63, pp. 439-446, (1986)
  • [25] Frey C.F., Child C.G., Fry W., Pancreatectomy for chronic pancreatitis, Ann Surg, 184, pp. 403-414, (1976)
  • [26] Del Prato S., Tiengo A., Baccaglini U., Et al., Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy, Diabetologia, 25, pp. 252-259, (1983)
  • [27] Jarvinen H.Y., Kiviluoto T., Taskinen M.R., Insulin resistance is a prominent feature of patients with pancreatogenic diabetes, Metabolism, 35, pp. 718-727, (1986)
  • [28] Bajorunas D.R., Dresler C.M., Horowitz G.D., Et al., Basal glucagon replacement in chronic glucagon deficiency increases insulin resistance, Diabetes, 35, pp. 556-562, (1986)
  • [29] Bajorunas D.R., Fortner J.G., Jaspan J.B., Glucagon immunoreactivity and chromatographic profiles in pancreatectomized humans: paradoxical response to oral glucose, Diabetes, 35, pp. 886-893, (1986)
  • [30] Bennett L.L., What causes fatty liver after pancreatectomy-an unresolved and forgotten controversy?, Perspect Biol Med, 26, pp. 595-612, (1983)